This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: D.e. Shaw Research, LLC, Relay Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 31 
1 out of 14 Years Active: 2026
Title: Bakary-Barry Touré: Innovator in FGFR Inhibitors
Introduction
Bakary-Barry Touré is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. His work focuses on novel compounds and methods that have the potential to treat disorders associated with FGFR signaling.
Latest Patents
Touré holds a patent for FGFR inhibitors and methods of use thereof. The patent details novel compounds of formula I-1, along with pharmaceutical compositions and methods for inhibiting the activity of FGFR enzymes. This innovation is crucial for developing treatments for various disorders linked to FGFR signaling.
Career Highlights
Throughout his career, Touré has worked with prominent companies in the biotechnology sector. He has been associated with Relay Therapeutics, Inc. and D.E. Shaw Research, LLC, where he has contributed to groundbreaking research and development efforts.
Collaborations
Touré has collaborated with esteemed colleagues, including Heike Schoenherr and Alexander M. Taylor. These partnerships have enhanced his research and innovation in the field of FGFR inhibitors.
Conclusion
Bakary-Barry Touré is a distinguished inventor whose work on FGFR inhibitors has the potential to impact the treatment of various disorders. His contributions to the pharmaceutical industry highlight the importance of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile